In last trading session, TherapeuticsMD Inc (NASDAQ:TXMD) saw 0.16 million shares changing hands with its beta currently measuring 1.17. Company’s recent per share price level of $1.11 trading at -$0.03 or -2.63% at ring of the bell on the day assigns it a market valuation of $12.80M. That closing price of TXMD’s stock is at a discount of -147.75% from its 52-week high price of $2.75 and is indicating a premium of 36.94% from its 52-week low price of $0.70. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 1.68 million shares which gives us an average trading volume of 280.18K if we extend that period to 3-months.

For TherapeuticsMD Inc (TXMD), analysts’ consensus is at an average recommendation of Buy while assigning it a mean rating of 3.00. Splitting up the data highlights that, out of 1 analysts covering the stock, 0 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 0 suggested the stock as a Hold whereas 1 see the stock as a Buy. 0 analyst(s) advised it as an Underweight.

TherapeuticsMD Inc (NASDAQ:TXMD) trade information

Upright in the red during last session for losing -2.63%, in the last five days TXMD remained trading in the green while hitting it’s week-highest on Friday, 01/03/25 when the stock touched $1.11 price level, adding 54.51% to its value on the day. TherapeuticsMD Inc’s shares saw a change of 29.07% in year-to-date performance and have moved 29.07% in past 5-day. TherapeuticsMD Inc (NASDAQ:TXMD) showed a performance of -9.76% in past 30-days. Number of shares sold short was 21273.0 shares which calculate 0.99 days to cover the short interests.

TherapeuticsMD Inc (TXMD) estimates and forecasts

Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of 49.33% during past 5 years.

TherapeuticsMD Inc (NASDAQ:TXMD)’s Major holders

Insiders are in possession of 1.71% of company’s total shares while institution are holding 44.53 percent of that, with stock having share float percentage of 45.30%. Investors also watch the number of corporate investors in a company very closely, which is 44.53% institutions for TherapeuticsMD Inc that are currently holding shares of the company. RUBRIC CAPITAL MANAGEMENT LP is the top institutional holder at TXMD for having 1.19 million shares of worth $1.92 million. And as of 2024-06-30, it was holding 10.3381 of the company’s outstanding shares.

The second largest institutional holder is CLEARLINE CAPITAL LP, which was holding about 0.64 million shares on 2024-06-30. The number of shares represents firm’s hold over 5.5205 of outstanding shares, having a total worth of $1.02 million.